New study highlights effectiveness and cost benefits of Myriad in lower limb salvage surgeries.
AUCKLAND, New Zealand, Jan. 17, 2025 /PRNewswire/ -- New Zealand headquartered soft…
New study highlights effectiveness and cost benefits of Myriad in lower limb salvage surgeries.
AUCKLAND, New Zealand, Jan. 17, 2025 /PRNewswire/ -- New Zealand headquartered soft…
IBM Study: AI Spending Expected to Surge 52% Beyond IT Budgets as Retail Brands Embrace Enterprise-Wide Innovation
The report found that 81% of surveyed executives and 96% of their…
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER…
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle
December 13, 2024 03:00 ET | Source: Actimed Therapeutics London, UK –…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute…
HP Wolf Security Study Reveals Platform Security Gaps That Threaten Organizations at Every Stage of the Device Lifecycle
The report highlights cybersecurity challenges facing organizations across the lifecycle of their…